© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.
DW Healthcare Partners invests in Vets Plus and Noble Pharma
The partnership provides growth capital and management expertise to Vets Plus.
DW Healthcare Partners DWHP, a healthcare-focused private equity firm, announced the completion of its investment in Vets Plus, Inc, and Noble Pharma, LLC. Vets Plus is a full-service developer and manufacturer of nutraceutical solutions for the companion animal and livestock markets. Noble Pharma is an-FDA registered manufacturer of animal health pharmaceuticals.
"Our partnership with DWHP provides the growth capital and management depth to improve our CMO customer relationships, expand our capabilities, accelerate new product commercialization, and scale operations," said Dave Nelson, President and Chief Executive Officer at Vets Plus.
"DWHP brings extensive market knowledge and a heightened level of sophistication to the Company. We are extremely blessed to have a strategic partner who shares our vision of superior customer service and best-in-class quality systems," he added.
Founder and current CEO of Vets Plus, Raj Lall, will pass daily responsibilities to Dave Nelson, who will take over as President and CEO. Raj will remain an owner and continue to serve on the board of directors. Doug Schillinger, Eric Moore, Paul Hays, and Dr Chandralal Weerasignhe will join Lall on the board of directors at Vets Plus.
"We are thrilled to be partnering with Raj Lall, Dave Nelson, Alok Kulshreshtha, and the rest of the team," said Schillinger, Managing Director at DWHP. "They have a proven track record of innovative growth. We look forward to supporting them as the business continues to scale in its traditional nutraceutical market and develops more complex pharmaceuticals at Noble."
"DWHP is the right partner for us going forward to help grow our pharmaceutical presence and gain market share in our nutraceutical business,” said Lall. “I'm excited for the next leg of our journey as I focus on research, product development, and serving on the board. I have complete confidence in Dave Nelson who has led our day-to-day operations as President for the past six years and will lead the Company as CEO."
Reference
DW Healthcare Partners Invests in Vets Plus. PRNewswire. January 10, 2022. Accessed January 11, 2022. https://www.prnewswire.com/news-releases/dw-healthcare-partners-invests-in-vets-plus-301456815.html
